News Release

Safety first: The American Heart Association's Scientific Sessions 2020 goes virtual

Meeting Announcement

American Heart Association

DALLAS, Wednesday, July 15, 2020 - After months of thorough, thoughtful review and discussion, and with a continued commitment to the health and safety of participants and staff, the American Heart Association will present Scientific Sessions 2020 as a 100% virtual experience in light of the impact of the COVID-19 pandemic. The event will be held November 13-17, 2020, with registration opening in mid-August.

The American Heart Association's Board of Directors and the Committee on Scientific Sessions Programming are focused on providing a robust and meaningful scientific exchange in a virtual format to help ensure the health and safety of all.

"AHA's Scientific Sessions is the premier venue for presenting the latest novel scientific and clinical ideas in cardiovascular disease, brain health and related conditions, with a global reach to millions. A virtual meeting will allow us to reach more people than ever, in real-time and asynchronously, with live chats that encourage meaningful dialogue about the science shared. We have so many innovations for our attendees - we look forward to providing an engaging and robust virtual experience in November!" said Donald M. Lloyd-Jones, M.D., Sc.M., FAHA, chair of the Association's Scientific Sessions Program Committee, president-elect of the Association, and Eileen M. Foell Professor of Heart Research, professor of preventive medicine, medicine and pediatrics, and chair of the department of preventive medicine at Northwestern University's Feinberg School of Medicine in Chicago.

###

Additional Resources:

American Heart Association Scientific Sessions logo is on right column of release link https://newsroom.heart.org/news/safety-first-the-american-heart-associations-scientific-sessions-2020-goes-virtual

Follow AHA/ASA news on Twitter @HeartNews

The Association receives funding primarily from individuals. Foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.